Inovio Pharmaceuticals Inc. Stock Falls 21.9%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. plummeted 21.9% to $0.60 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 2.9% to 25,437.00 and Dow Jones Industrial Average falling 1.1% to 51,770.31.

This was the stock's second consecutive day of losses.

Inovio Pharmaceuticals Inc. closed 77.9% short of its 52-week high of $2.72, which the company reached on December 17th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.7% to $273.20, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 1.90% to $30.52.

Trading volume totaled 17.1 million, compared to the 50-day average of 3.7 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 30, 2026 16:33 ET (20:33 GMT)